Paragraph IV Patent Challenges: How Generic Makers Challenge Brands
Learn how generic drug makers use Paragraph IV certifications to challenge brand patents under the Hatch-Waxman Act. Discover the 180-day exclusivity rule, the 30-month stay, and the economic impact on drug prices.